Уноси · Publikacije Univerziteta u Banjoj Luci

Unosi

Role of COPD in decision-making process of myocardial revascularization: a retrospective analysis from a single PCI-centre without on-site cardiac surgery. (2015-05)

B. Stanetić, T. Kovačević-Preradović, M. Stanetić, S. Lončar, Ž. Živanović, S. Srdić, K. Huber, P. Serruys, M. Ostojić, Role of COPD in decision-making process of myocardial revascularization: a retrospective analysis from a single PCI-centre without on-site cardiac surgery., ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, pp. 10 - 16, May, 2015
Role of COPD in Decision-Making Process of Myocardial Revascularisation: A Retrospective Analysis from a Single PCI-centre Without On-site Cardiac Surgery. (2015-05)

B. Stanetić, T. Kovačević-Preradović, M. Stanetić, S. Lončar, Ž. Živanović, S. Srdić, K. Huber, P. Serruys, Role of COPD in Decision-Making Process of Myocardial Revascularisation: A Retrospective Analysis from a Single PCI-centre Without On-site Cardiac Surgery., Časopis udruženja pulmologa Republike Srpske, Vol. 5, No. 1-2, pp. 9 - 16, May, 2015
Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption (2015-06)

P. Suwannasom, Y. Onuma, C. Campos, S. Nakatani, Y. Ishibashi, H. Tateishi, M. Grundeken, B. Stanetić, K. Nieman, H. Jonker, H. Garcia-Garcia, P. Serruys, Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 8, No. 8, pp. 1130 - 1132, Jun, 2015
Novel bioresorbable scaffolds technologies: current status and future directions. (2015-08)

B. Stanetić, J. Iqbal, Y. Onuma, P. Serruys, Novel bioresorbable scaffolds technologies: current status and future directions., Minerva Cardioangiologica , Vol. 63, No. 4, pp. 297 - 315, Aug, 2015
Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. (2015-11)

B. Stanetić, C. Campos, V. Farooq, S. Walsh, Y. Ishibashi, Y. Onuma, H. Garcia-Garcia, J. Escaned, A. Banning, P. Serruys, Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial., CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 15, No. 86, pp. 229 - 238, Nov, 2015
Appropriateness of myocardial revascularization assessed by the SYNTAX Score II in a country without cardiac surgery facilities. (2016-05)

B. Stanetić, C. Campos, v. Farooq, T. Kovačević-Preradović, K. Huber, M. Ostojić, P. Serruys, Appropriateness of myocardial revascularization assessed by the SYNTAX Score II in a country without cardiac surgery facilities., ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, pp. 75 - 84, May, 2016
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016-06)

J. Escaned, A. Banning, V. Farooq, M. Echavarria-Pinto, Y. Onuma, N. Ryan, R. Calvacante, C. Campos, B. Stanetić, Y. Ishibashi, P. Suwannasom, A. Kappetein, D. Taggart, M. Morel, G. van Es, P. Serruys, Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease., EuroIntervention, Vol. 12, No. 2, pp. 224 - 234, Jun, 2016
ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. (2017-01)

BM. Stanetić, M. Ostojić, C. Campos, J. Marinkovic, V. Farooq, T. Kovačević-Preradović, K. Huber, P. Serruys, ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study., INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol. 227, pp. 478 - 484, Jan, 2017
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017-02)

C. Collet, T. Asano, Y. Sotomi, R. Calvacante, B. Stanetić, Y. Miyazaki, Y. Zeng, K. Tummala, J. Tijssen, R. De Winter, Y. Onuma, D. Capodanno, P. Serruys, Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies., Minerva Cardioangiologica (Testo stampato), Vol. 65, No. 1, pp. 32 - 51, Feb, 2017
Prediktivne performanse SYNTAX sCore II kod pacijenata sa značajnom stenozom glavnog stabla ili trosudovnom koronarnom bolesti srca tretiranih sa „bare-metal” stentovima”. (2015)

B. Stanetić, T. Kovačević-Preradović, S. Lončar, N. Dobrijević, S. Srdić, P. Serruys, M. Ostojić, Prediktivne performanse SYNTAX sCore II kod pacijenata sa značajnom stenozom glavnog stabla ili trosudovnom koronarnom bolesti srca tretiranih sa „bare-metal” stentovima”., Suplement sažetaka saopštenih na XX Kogresu udruženja kardiologa Srbije, Zlatibor. Srce i krvni sudovi 2015; Srce i krvni sudovi 2015; 34(3): 93., 2015
aPProPriateness oF myoCardial revasCularization assessed By SYNTAX sCore II in a Centre without on-site CardiaC surgery. (2015)

B. Stanetić, M. Ostojić, K. Huber, C. Campos, T. Kovačević-Preradović, P. Serruys, aPProPriateness oF myoCardial revasCularization assessed By SYNTAX sCore II in a Centre without on-site CardiaC surgery., JACC Mart 17, 2015;65:10s, 2015
Current Situation Of Bioresorbable Vascular Scaffolds And Its Impact On Clinical Practice. (2015-03)

B. Stanetić, P. Serruys, Current Situation Of Bioresorbable Vascular Scaffolds And Its Impact On Clinical Practice., Mar, 2015
Appropriateness Of Myocardial Revascularization Assessed By Syntax Score II In A Centre Without On-Site Cardiac Surgery. (2015-03)

B. Stanetić, M. Ostojić, K. Huber, C. Campos, T. Kovačević-Preradović, P. Serruys, Appropriateness Of Myocardial Revascularization Assessed By Syntax Score II In A Centre Without On-Site Cardiac Surgery., Journal of American College of Cardiology., Mar, 2015
Natural history of coronary calcification: A 5-year serial optical coherence tomography study (2015-10)

M. Nato, C. Campos, H. Garcia-Garcia, B. Stanetić, S. Veldhof, P. Serruys, Natural history of coronary calcification: A 5-year serial optical coherence tomography study, Journal of American College of Cardiology, Oct, 2015
Risk Stratification in 3- Vessel Coronary Artery Disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II Trial. (2016)

C. Campos, B. Stanetić, V. Farooq, S. Walsh, Y. Ishibashi, Y. Onuma, H. Garcia-Garcia, J. Escaned, A. Banning, P. Serruys, Risk Stratification in 3- Vessel Coronary Artery Disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II Trial., 2016
Appropriateness of Myocardial Revascularization in Patients with Complex Coronary Artery Disease Assessed by the SYNTAX Score II. (2017-01)

B. Stanetić, M. Ostojic, T. Kovačević-Preradović, K. Huber, M. Rohla, I. Tentzeris, P. Serruys, Appropriateness of Myocardial Revascularization in Patients with Complex Coronary Artery Disease Assessed by the SYNTAX Score II., Jan, 2017

Unosi

Role of COPD in decision-making process of myocardial revascularization: a retrospective analysis from a single PCI-centre without on-site cardiac surgery. (2015-05)

Role of COPD in Decision-Making Process of Myocardial Revascularisation: A Retrospective Analysis from a Single PCI-centre Without On-site Cardiac Surgery. (2015-05)

Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption (2015-06)

Novel bioresorbable scaffolds technologies: current status and future directions. (2015-08)

Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. (2015-11)

Appropriateness of myocardial revascularization assessed by the SYNTAX Score II in a country without cardiac surgery facilities. (2016-05)

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016-06)

ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. (2017-01)

Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017-02)

Prediktivne performanse SYNTAX sCore II kod pacijenata sa značajnom stenozom glavnog stabla ili trosudovnom koronarnom bolesti srca tretiranih sa „bare-metal” stentovima”. (2015)

aPProPriateness oF myoCardial revasCularization assessed By SYNTAX sCore II in a Centre without on-site CardiaC surgery. (2015)

Current Situation Of Bioresorbable Vascular Scaffolds And Its Impact On Clinical Practice. (2015-03)

Appropriateness Of Myocardial Revascularization Assessed By Syntax Score II In A Centre Without On-Site Cardiac Surgery. (2015-03)

Natural history of coronary calcification: A 5-year serial optical coherence tomography study (2015-10)

Risk Stratification in 3- Vessel Coronary Artery Disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II Trial. (2016)

Appropriateness of Myocardial Revascularization in Patients with Complex Coronary Artery Disease Assessed by the SYNTAX Score II. (2017-01)